D. E. Shaw & Co., Inc. - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAC0. A total of 11 filers reported holding ACORDA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,980,000
-12.9%
14,000,0000.0%0.01%
-11.1%
Q2 2023$9,161,250
+4.5%
14,000,0000.0%0.01%0.0%
Q1 2023$8,767,500
-1.1%
14,000,0000.0%0.01%
-10.0%
Q4 2022$8,868,900
-14.7%
14,000,0000.0%0.01%
-16.7%
Q3 2022$10,399,000
-0.3%
14,000,0000.0%0.01%0.0%
Q2 2022$10,435,000
-2.1%
14,000,0000.0%0.01%
+20.0%
Q1 2022$10,662,000
-4.7%
14,000,0000.0%0.01%
+11.1%
Q4 2021$11,193,000
-0.6%
14,000,0000.0%0.01%
-10.0%
Q3 2021$11,255,000
+9.0%
14,000,0000.0%0.01%
+11.1%
Q2 2021$10,328,000
+1.8%
14,000,0000.0%0.01%
-10.0%
Q1 2021$10,143,00014,000,0000.01%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 25,875,000$19,021,0001.51%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 45,283,000$34,415,0000.78%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 52,324,000$38,202,0000.66%
UBS OCONNOR LLC 30,000,000$22,523,000,0000.33%
Soros Fund Management 28,001,000$16,213,0000.29%
Saltoro Capital, LP 1,500,000$1,110,0000.27%
D. E. Shaw & Co., Inc. 14,000,000$10,435,0000.01%
WELLS FARGO & COMPANY/MN 5,018,000$3,814,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACORDA THERAPEUTICS INC shareholders